Optimized gRNA Library Design for CRISPR Editing Accuracy

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current methods for selecting guide RNAs (gRNAs) for CRISPR/Cas9-mediated gene editing are limited by suboptimal predictive algorithms, leading to inefficient and unpredictable genetic modifications, increasing the expense and difficulty of genetic screens.

Innovation Solution

A high-throughput method involving nucleic acid constructs with gRNA and sensor sequences is used to identify gRNAs that produce specific genetic modifications by expressing these constructs in cells engineered to express Cas9, amplifying, sequencing, and analyzing the resulting DNA alterations to determine optimal gRNA libraries for specific gene editing outcomes.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Measurement precision

If suboptimal predictive algorithms are used for selecting guide RNAs, then the selection process is simple, but the accuracy and predictability of genetic modifications decrease

Engineering Contradiction:
Improveaccuracy of genetic modification predictionVSAvoidcomplexity of selection method
Core Design Contradiction:
Measurement precisionVSDevice complexity

Solution Approach 1:

The patent performs preliminary functional testing of guide RNAs in a high-throughput manner before actual genome editing experiments. By pre-screening gRNAs using a standardized assay system that measures editing efficiency and specificity, the method identifies optimal guides in advance, eliminating the need for complex predictive algorithms during the actual editing process and improving accuracy through empirical data.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent implements a feedback mechanism where the results of high-throughput functional assays are used to refine and optimize guide RNA selection. The systematic collection and analysis of editing outcomes from multiple gRNAs provide feedback that enables identification of determinants for successful editing, allowing continuous improvement of selection criteria without increasing algorithmic complexity.

Inventive Principle:
Principle #23Feedback

2Productivity

If non-functional or hypo-functional guide RNAs are used, then the library size increases, but the expense and difficulty of genetic screens increase

Engineering Contradiction:
Improveefficiency of genetic screensVSAvoidnumber of guide RNAs required
Core Design Contradiction:
ProductivityVSQuantity of substance

Solution Approach 1:

The patent extracts and removes non-functional and hypo-functional guide RNAs from the library through high-throughput functional screening. By systematically testing each gRNA's editing capability and eliminating those that fail to produce desired modifications, the method reduces the effective library size to contain only functional guides, thereby decreasing the expense and difficulty of subsequent genetic screens while maintaining comprehensive coverage.

Inventive Principle:
Principle #2Taking out (Extraction)

Solution Approach 2:

The patent initially screens a larger number of guide RNAs than strictly necessary (excessive action) to ensure comprehensive identification of functional guides. This approach allows for selection of the most effective subset, ensuring that enough functional gRNAs are identified to cover all target genes adequately, while eliminating redundant non-functional guides from the final library.

Inventive Principle:
Principle #16Partial or excessive action

3Reliability

If empirical studies and predictive algorithms are used to identify functional guide RNAs, then some functional guides are identified, but a significant number still fail to result in desired gene editing

Engineering Contradiction:
Improvereliability of guide RNA functionVSAvoidcomplexity of identification method
Core Design Contradiction:
ReliabilityVSDevice complexity

Solution Approach 1:

The patent employs a self-service approach where the guide RNA library itself is used to identify functional guides through high-throughput functional assays. The system automatically tests each gRNA's editing efficiency and specificity, allowing the data to speak for itself rather than relying on external predictive algorithms. This empirical self-evaluation significantly improves reliability by directly measuring actual editing outcomes.

Inventive Principle:
Principle #25Self-service

Solution Approach 2:

The patent systematically varies and analyzes multiple parameters of guide RNA sequences (such as nucleotide composition, secondary structure, and target site characteristics) to identify determinants of functional efficacy. By examining these parameters in the context of actual editing outcomes, the method establishes reliable criteria for predicting guide RNA success, improving reliability while maintaining manageable complexity through focused parameter analysis.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

This approach enables the identification of gRNAs that result in specific and predictable genetic modifications, reducing the number of required guides and minimizing off-target effects, thereby improving the efficiency and accuracy of genome engineering.

Implementation Method 1

use of clustered regularly interspaced short palindromic repeats (CRISPR) gene editing technology

Methodology Applied
Scientific EffectComplementary base pairing:

Implementation Method 2

Cas9-targeting to a target sequence

Methodology Applied
Scientific EffectEnzymatic cleavage: Enzyme

Implementation Method 3

amplifying the nucleic acid constructs sequences by polymerase chain reaction (PCR) from the cells of step (b)

Methodology Applied
Scientific EffectPCR amplification:

Data Source

PatentUS11946163B2Methods for measuring and improving CRISPR reagent function
Publication Date: 2024.04.02 KSQ THERAPEUTICS INC
  • US11946163B2 patent drawing
  • US11946163B2 patent drawing
  • US11946163B2 patent drawing

AI summary

The invention describes a novel system for identifying optimized gRNAs for use in CRISPR/Cas9 genome editing platforms. The invention allows for the determination of specific gene alterations rendered by a particular gRNA, thereby permitting the generation of optimized gRNA libraries.